Warner-Lambert Company v Cardinal Health, Inc

Link copied
Case Copied 17 min read

ABSTRACTS OF DECISIONS

DECISION OF A DELEGATE OF THE COMMISSIONER OF PATENTS

Application  :          No. 762692 in the name of WARNER-LAMBERT COMPANY

Title:          Modified Starch Film Compositions

Action:          Application for an extension of time by CARDINAL HEALTH, INC to serve evidence in support, and an objection thereto by WARNER-LAMBERT COMPANY

Decision:          Issued  20 May 2005.

Abstract

Request for extension of time granted.

The explanation justified an extension of time.  While more detail was given at the hearing, nothing new was added.  The main points set out in the request did not change.

While lack of utility was a ground of opposition which was distinct from the other grounds available (as per the comments of Gummow J in Lockwood Security Products Pty Ltd v. Doric Products Pty Ltd [2004] HCA 58 at 46 and 48), and gathering evidence for one should not necessarily delay the gathering and filing of evidence for the other, it is also plausible that there may be overlap between them that necessitates waiting for one to be completed before it can be served. Without knowing exactly what the evidence will be, it is not always possible to reach a conclusion one way or the other.

Despite submissions to the contrary, it seems clear from the explanations that a serious opposition is in train.  In addition, the opponent’s decision to perform commercial-scale experiments only after finding something worth investigating from laboratory experiments is reasonable.  Naturally, if the opponent had not proceeded expeditiously in setting up commercial-scale experiments following their laboratory experiments, there might be some justification in refusing an extension.  However, there was no evidence of this.

On balance the parties’ interests supported an extension, as did the public interest in having a serious opposition decided on its merits.

Costs awarded against Warner-Lambert Company.

PATENTS ACT 1990

DECISION OF A DELEGATE OF THE COMMISSIONER OF PATENTS

Re:Patent Application No. 762692 by Warner-Lambert Company;

Application for an extension of time by Cardinal Health, Inc to serve evidence in support, and an objection thereto by Warner-Lambert Company

BACKGROUND

  1. Patent application 762692 in the name of Warner-Lambert Company (“Warner”) was filed on 11 August 1999 as PCT/US99/18139 for an invention titled “Modified Starch Film Compositions”.  The application was advertised accepted on 3 July 2003.  On 2 October 2003, Cardinal Health, Inc (“Cardinal”) filed a notice of opposition.  A Statement of Grounds and Particulars followed on 24 December 2003.  Therefore, evidence in support was due 24 March 2004.  Cardinal requested, and was granted, several extensions up to 24 December 2004 to serve evidence in support.

  2. On 16 November 2004, following the amendment of the Patents Act by the US Free Trade Agreement Implementation Act 2004, Cardinal filed an amended Statement of Grounds and Particulars adding the ground of lack of utility (as found in s.18(1)(c)), including particulars in support, as permitted by the Commissioner in her Official Notice in the AOJP of 26 August 2004. The amendment was accompanied by a request to file further evidence relating to the…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Warner-Lambert Company v Cardinal Health, Inc and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2005] APO 26
Decision Date

CaseChat Overview and Summary

Warner-Lambert Company filed a patent application for "Modified Starch Film Compositions." Cardinal Health, Inc. opposed the application, adding a new ground of opposition concerning lack of utility. Cardinal applied for an extension to submit supporting evidence, which Warner-Lambert Company opposed. The dispute centred on whether the reasons provided for the extension justified the requested additional time.

The court had to decide if the reasons provided for the extension justified the requested additional time. The considerations included the explanation for the delay, the parties' interests, and the public interest. Warner-Lambert Company argued that the explanation was insufficient and inconsistent, and that the delay prejudiced their interests. Cardinal Health, Inc. countered that the explanation was adequate and that the delay was due to unavoidable circumstances. The court also had to consider whether the extension would unduly delay the proceedings and if it would prevent the opposition from being heard on its merits.

The court found that the explanation justified the extension. While there were some inconsistencies, the court considered the main points of the explanation to be present. The court accepted that the reasons provided were plausible and that there might be some overlap between the grounds of opposition that necessitated waiting for one to be completed before serving the other. The court found that the parties' interests supported the extension, as there was no special disadvantage to Warner-Lambert Company if the extension were granted. Furthermore, the public interest supported the extension because it was important for a serious opposition to be heard on its merits. The court granted the extension and awarded costs against Warner-Lambert Company.

The court granted the extension and awarded costs against Warner-Lambert Company. The time for filing evidence in support was extended to 24 June 2005.

Background

Background to the litigation

Patent application number 762692, titled "Modified Starch Film Compositions," was filed by Warner-Lambert Company on 11 August 1999. The application was advertised as accepted on 3 July 2003. On 2 October 2003, Cardinal Health, Inc filed a notice of opposition. A Statement of Grounds and Particulars followed on 24 December 2003, with evidence in support due by 24 March 2004. Cardinal Health, Inc had been granted several extensions up to 24 December 2004 to serve evidence in support. Following the amendment of the Patents Act by the US Free Trade Agreement Implementation Act 2004, Cardinal Health, Inc filed an amended Statement of Grounds and Particulars on 16 November 2004, adding the ground of lack of utility. Cardinal Health, Inc requested, and was granted, an extension to file further evidence relating to the new ground, with the indulgence that the further evidence could be served at the same time as the evidence in support. Cardinal Health, Inc requested a further extension to 24 March 2005, which was granted. On 24 March 2005, Cardinal Health, Inc requested another 3-month extension in which to file evidence in support, which Warner-Lambert Company objected to.

The application for an extension of time to file evidence in support, and the objection thereto, was heard in Canberra on 21 April 2005. Both parties appeared by telephone. Ms Julie Harkins, patent attorney of Callinan Lawrie, Kew represented Warner-Lambert Company. Ms Marita Gill, patent attorney, assisted by Mr Greg Chambers, both of Phillips Ormonde & Fitzpatrick, Melbourne appeared for Cardinal Health, Inc. As at the hearing date, no evidence in support had been filed.

Decision

Reasons for decision

Issues
1. Whether the explanation provided justifies granting an extension of time to serve evidence in support.
2. Whether the interests of the parties support granting the extension.
3. Whether the public interest supports granting the extension.

Held
1. The explanation provided justifies granting an extension of time to serve evidence in support.
2. The interests of the parties support granting the extension.
3. The public interest supports granting the extension.

Ratio Decidendi

Legal Principle Established

The court examined the request for an extension of time by Cardinal Health, Inc. to serve evidence in support of their opposition to Warner-Lambert Company's patent application, and the objection by Warner-Lambert Company. The decision to grant the extension was based on the explanation provided by Cardinal, the interests of the parties, and the public interest.

Firstly, the court found that the explanation provided by Cardinal justified the extension of time. Although Warner-Lambert Company raised concerns about inconsistencies in the explanation, the court concluded that the main points made at the hearing were present in the explanation and that there was sufficient progress in preparing the evidence to justify the extension. The court also considered the arguments that the need for commercial-scale experiments and the importation of reagents were reasonable and not entirely predictable.

Secondly, the court found that the interests of the parties supported granting the extension. Warner-Lambert Company argued that the extension would delay the grant of the patent, but the court did not find any special reasons that would specifically disadvantage them if the extension were granted.

Lastly, the court found that the public interest supported granting the extension. The court balanced the need for expeditious disposal of matters before the Patent Office with the importance of determining a serious opposition on its merits to prevent the grant of clearly invalid patents. The court concluded that it was in the public interest to have the opposition determined on its merits, even if it meant delaying the grant of the patent.

The ratio decidendi of this case is that the Commissioner of Patents may grant an extension of time to serve evidence in support if reasonably satisfied that it is appropriate in all of the circumstances, considering the explanation provided, the interests of the parties, and the public interest.